If you missed it, the new FundAlarm.com highlights and commentary page is new for November.

CVS (CVS)-Caremark RX (CMX)?

Barnaby J. Feder in the New York Times on those who doubt the logic of the deal. DealBook reports on the defense of the deal. Robert Cyran at breakingviews thinks the companies are “running scared.” Chad Brand at the Peridot Capitalist wonders whether this deal will put pressure on the competition.

Tom Lydon at ETF Trends points out an interesting study on fund ownership in America.

Sue Stevens at Morningstar.com on the pros and cons of ETFs.

Paul Kedrosky at Infectious Greed on the “private equity” ETF.

Sinclair Stewart and Andrew Willis in the Globe & Mail on the reason why the Canadian government chose to crackd0wn on income trusts.

Greg Newton at NakedShorts on the overuse of the term, blow-up, in regards to hedge fund failure.

All About Alpha reviews a paper on hedge fund replication.

Mark Gilbert at Bloomberg.com on the continued risk in hedge fund risk taking.

David Roeder in the Chicago Sun Times with some backstory on CME-CBOT dealmaking.

CXO Advisory Group on the challenges of using investment advice.

Accrued Interest on the worrying trends in labor costs.

Eddy Elfenbein at Crossing Wall Street with some questions on trend GDP growth rates.

Tyler Cowen at Slate.com on the economics of eating, and again in the New York Times on an new economics book that focuses on the importance of human capital in wealth creation.

While we were gone we hope you did not forget how to add our feed to your favorite feed reader.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.

Please see the Terms & Conditions page for a full disclaimer.